Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. International Laboratories (Canada) Ltd.
WARNING LETTER
•International Laboratories (Canada) Ltd.•February 16, 2012

International Laboratories (Canada) Ltd. – FDA Warning Letter, Feb 16, 2012

Record Details

On October 23, 2012, the FDA issued a Warning Letter to International Laboratories (Canada) Ltd. following a February 13-16, 2012 inspection. The inspection revealed significant violations of current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211) for finished pharmaceuticals, rendering their drug products adulterated.

Key violations include: 1. **Supplier Reliability (21 CFR § 211.84(d)):** The firm failed to validate supplier analyses or conduct specific identity tests for incoming components, relying solely on Certificates of Analysis. 2. **Specifications and Test Procedures (21 CFR § 211.160(b)):** The firm lacked scientifically sound specifications, sampling plans, and test procedures, including finished product specifications and identity/assay tests for their (b)(4) product. 3. **Quality Control Unit (QCU) Deficiencies (21 CFR § 211.22):** The QCU lacked established SOPs, oversight for finished product release, specifications for components, and failed to follow testing procedures for (b)(4). 4. **Master Production and Control Records (21 CFR § 211.186(b)):** Records lacked accurate component weights, theoretical yield statements, and complete manufacturing instructions. A change management program was also absent

Company
International Laboratories (Canada) Ltd.
Inspection date
February 16, 2012
Product type
Drugs
Office
Department of Health and Human Services
Person
  • Steven J. Lynn
View Company Profile

ID · 25c47a51-2652-4314-9854-34f80dd0ad92

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)21 CFR 211.84(d)21 CFR 211.160(b)21 CFR 211.2221 CFR 211.186(b)21 CFR 211.25(a)21 CFR 701.13(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore International Laboratories (Canada) Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.